Eli Lilly CEO David Ricks bought just over $1 million of Lilly shares in the open market Tuesday following the sharp drop in ...

Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...

Eli Lilly’s weight-loss pill disappointed in a key trial, but CEO David Ricks and other insiders together bought nearly $3 ...

CNBC’s Angelica Peebles and Eli Lilly chairman and CEO David Ricks join 'Squawk Box' to discuss the company's quarterly earnings results, late-stage trial data on its experimental obesity pill ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body weight.

More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lilly is the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.

Welcome to the program. CHAIRMAN & CEO OF ELI LILLY DAVID RICKS: Great to be with you today. MARGARET BRENNAN: It's so good to have you on the podcast.

We sat down with Lilly Chairman and CEO Dave Ricks to talk about innovation, real estate, the company's recent acquisition of a hearing loss gene therapy company and its future in biotech hubs ...

Eli Lilly CEO David Ricks, speaking to the slow and steady progress that brought tirzepitide to the world, says the Indianapolis pharma is now ready to open up the chocolate factory.

Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.

Eli Lilly and Co. CEO David Ricks spoke to the Economic Club of Indiana on April 20, in part about challenges in Indiana’s business climate. The following is a transcript, edited for space and ...

WEST LAFAYETTE, Ind. — Purdue men’s basketball coach Matt Painter’s conversation with Eli Lilly and Co. chairman and CEO Dave Ricks will highlight Lilly Day at Purdue on Wednesday (Aug. 29). The ...